VERU INC. Foreign Currency Transaction Gain, before Tax
VERU INC. (VERU) reported Foreign Currency Transaction Gain, before Tax of $15.23 thousand for the 3-month period ending 2012-06-30, per its 10-Q filed 2013-08-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2013-08-01
- VERU INC. foreign currency transaction gain, before tax for the quarter ending 2012-06-30 was $15.23K.
| Period end | Foreign Currency Transaction Gain, before Tax 3 month |
|---|---|
| 2012-06-30 | $15.23K 10-Q · filed 2013-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |